Floatz logo

1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
7mw3711 for
Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.P1/2CC (40)
9mw2821
Cancer
Convalife (Shanghai) Co., Ltd.P1/2CC (40)
9mw2921
Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.P1/2CC (40)
Abt-101
Cancer
Anbogen Therapeutics, Inc.P1/2CC (40)
Adg 106
Cancer
National University Hospital, SingaporeP1/2CC (40)
ai-081
Cancer
OncoC4, Inc.P1/2CC (40)
ak129
Cancer
AkesoP1/2CC (40)
Alk-N001 For
Cancer
Zhejiang Anglikang Pharmaceutical Co., Ltd.P1/2CC (40)
Amt-253 For
Cancer
Multitude Therapeutics Inc.P1/2CC (40)
anv600
Cancer
Anaveon AGP1/2CC (40)
ap402
Cancer
AP Biosciences Inc.P1/2CC (40)
art6043
Cancer
Artios Pharma LtdP1/2CC (40)
Askg915
Cancer
AskGene Pharma, Inc.P1/2CC (40)
asp1570
Cancer
Astellas Pharma Global Development, Inc.P1/2CC (40)
Atg-016
Cancer
Shanghai Antengene Corporation LimitedP1/2CC (40)
Atrn-119
Cancer
Aprea TherapeuticsP1/2CC (40)
Autologous Cd8+ T-Cells, Transduced With Mage-A1 Directed Tcr
Cancer
T-knife GmbHP1/2CC (40)
Avzo-021
Cancer
Avenzo Therapeutics, Inc.P1/2CC (40)
bat1006 for
Cancer
Bio-Thera SolutionsP1/2CC (40)
bat8010 for
Cancer
Bio-Thera SolutionsP1/2CC (40)
Blu-924
Cancer
Blueprint Medicines CorporationP1/2CC (40)
Bms-986442
Cancer
Bristol-Myers SquibbP1/2CC (40)
Bms-986449
Cancer
Bristol-Myers SquibbP1/2CC (40)
Bms-986482
Cancer
Bristol-Myers SquibbP1/2CC (40)
Bms-986490
Cancer
Bristol-Myers SquibbP1/2CC (40)
bnt3212
Cancer
BioNTech SEP1/2CC (40)
bnt326
Cancer
BioNTech SEP1/2CC (40)
bnt327
Cancer
DualityBio Inc.P1/2CC (40)
Bpi-1178
Cancer
Beta Pharma (Suzhou) Co., Ltd.P1/2CC (40)
Bpi-572270
Cancer
Betta Pharmaceuticals Co., Ltd.P1/2CC (40)
bt7480
Cancer
BicycleTx LimitedP1/2CC (40)
c610
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
can1012
Cancer
Canwell Biotech LimitedP1/2CC (40)
cgt4859
Cancer
Cogent Biosciences, Inc.P1/2CC (40)
Cjrb-101
Cancer
CJ Bioscience, Inc.P1/2CC (40)
Ckd-703
Cancer
Chong Kun Dang PharmaceuticalP1/2CC (40)
Clio-8221
Cancer
Callio TherapeuticsP1/2CC (40)
CM350
Cancer
Keymed Biosciences Co.LtdP1/2CC (40)
cm518d1
Cancer
Keymed Biosciences Co.LtdP1/2CC (40)
Conteltinib
Cancer
Shouyao Holdings (Beijing) Co. LTDP1/2CC (40)
cs2009
Cancer
CStone PharmaceuticalsP1/2CC (40)
Dalmitamig
Cancer
Regeneron PharmaceuticalsP1/2CC (40)
Dalpiciclib Isetionate
Cancer
Risen (Suzhou) Pharma Tech Co., Ltd.P1/2CC (40)
db-1202
Cancer
DualityBio Inc.P1/2CC (40)
db-1305/bnt325
Cancer
DualityBio Inc.P1/2CC (40)
db-1311
Cancer
DualityBio Inc.P1/2CC (40)
ds-3939a
Cancer
Daiichi SankyoP1/2CC (40)
dt-7012
Cancer
Domain Therapeutics Australia Pty LtdP1/2CC (40)
Duvelisib
Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P1/2CC (40)
Eb-Nk-301
Cancer
Beijing BiotechP1/2CC (40)
Showing 551 to 600 of 1,379 assets
PreviousPage 12 of 28Next